Member Spotlight: Stein Investment Management
Member Spotlight: Stein Investment Management Stein Investment Management, a US-based asset manager company, focuses on trading the S&P 500 and other stock index futures…
FON Editorial is the newsroom of Family Office Networks (FON), founded in 2014 by Andrew Schneider. The editorial team reports on family offices, ultra-high-net-worth investing, private markets, philanthropy, and luxury, under the FON Editorial Standards. Story tips and corrections: editorial@familyofficenetworks.com.
Member Spotlight: Stein Investment Management Stein Investment Management, a US-based asset manager company, focuses on trading the S&P 500 and other stock index futures…
MDBox enhanced telemedicine app is the company’s core platform - it uses A.I. and machine vision to integrate diagnostic tests, triage patients, and soon,…
Huvr Travelers can visit any city by virtually teleporting into a Huvr Walker in real time for an unprecedented safe and affordable travel experience…
The Pelorus Fund is a cannabis-focused commercial real estate mortgage REIT with a target annualized yield of 15% IRR. The Fund achieved an annualized…
xBeam 3D Metal Printing technology is a leader in The Fourth Industrial Revolution or Industry 4.0, which is driving the current transformation of traditional…
Timberland Partners Apartment Fund VII: A proven investment model over multiple market cycles Since its founding over 28 years ago, Timberland Partners has produced…
Family Office Networks Launches FON Marketplace as Innovative New Technology Platform Palm Beach, FL – (July 30, 2020) – Family Office Networks announced today…
AltaThera Pharmaceuticals LLC – Optimizing Care to Improve Patient Outcomes AltaThera Pharmaceuticals LLC is a commercial stage hospital-focused pharmaceutical company applying innovative science to…
We offer tailored real estate financing solutions to meet operator growth capital needs. Client Spotlight Freehold Properties Inc is an internally managed REIT focused…
REVANCE THERAPEUTICS: THE PRESTIGE MEDICAL AESTHETIC BIOTECH Revance is a Silicon Valley-based biotechnology company daring to make a difference by focusing on innovative aesthetic…
Protected by reCAPTCHA — the Google Privacy Policy and Terms of Service apply.